MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection

Publisher： Science Publishers

ISSN： 2049-9434

Source： Biomedical Reports, Vol.3, Iss.2, 2015-01, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 525-528

Spandidos Publications

Access to resources Recommend Favorite

Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin

By                        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1646-1650

Spandidos Publications

Access to resources Recommend Favorite

Effect of healthcare insurance policy on the quality of life of chronic hepatitis C patients receiving interferon α-2a plus ribavirin therapy

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 1062-1066

Spandidos Publications

Access to resources Recommend Favorite

Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 427-433

Spandidos Publications

Access to resources Recommend Favorite

Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 517-520

Spandidos Publications

Access to resources Recommend Favorite